142 related articles for article (PubMed ID: 37773098)
1. Economic burden of atherosclerotic cardiovascular disease: a matched case-control study in more than 450,000 Swedish individuals.
Steen Carlsson K; Nilsson K; Wolden ML; Faurby M
BMC Cardiovasc Disord; 2023 Sep; 23(1):483. PubMed ID: 37773098
[TBL] [Abstract][Full Text] [Related]
2. Atherosclerotic Cardiovascular Disease in Type 2 Diabetes: A Retrospective, Observational Study of Economic and Clinical Burden in Sweden.
Steen Carlsson K; Faurby M; Nilsson K; Wolden ML
Diabetes Ther; 2023 Aug; 14(8):1357-1372. PubMed ID: 37326822
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular events, mortality, early retirement and costs in >50 000 persons with chronic heart failure in Sweden.
Steen Carlsson K; Faurby M; Nilsson K; Wolden ML
ESC Heart Fail; 2024 Feb; 11(1):54-64. PubMed ID: 37814495
[TBL] [Abstract][Full Text] [Related]
4. Healthcare resource utilization and costs of cardiovascular events in patients with atherosclerotic cardiovascular disease in Germany - results of a claims database study.
Sidelnikov E; Dornstauder E; Jacob C; Maas C; Pinto L; Leidl R; Ahrens I
J Med Econ; 2022; 25(1):1199-1206. PubMed ID: 36330899
[TBL] [Abstract][Full Text] [Related]
5. Cystatin C Predicts Incident Cardiovascular Disease in Twins.
Arpegård J; Magnusson PK; Chen X; Ridefelt P; Pedersen NL; De Faire U; Svensson P
J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27353608
[TBL] [Abstract][Full Text] [Related]
6. Association Between Cardiovascular Event Type and Smoking Cessation Rates Among Outpatients With Atherosclerotic Cardiovascular Disease: Insights From the NCDR PINNACLE Registry.
Hejjaji V; Ellerbeck EF; Jones PG; Pacheco CM; Malik AO; Chan PS; Spertus JA; Arnold SV
Circ Cardiovasc Qual Outcomes; 2024 Feb; 17(2):e009960. PubMed ID: 38318702
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: estimates from Swedish population-based register data.
Lindh M; Banefelt J; Fox KM; Hallberg S; Tai MH; Eriksson M; Villa G; Svensson MK; Qian Y
Eur Heart J Qual Care Clin Outcomes; 2019 Jul; 5(3):225-232. PubMed ID: 30649251
[TBL] [Abstract][Full Text] [Related]
8. Burden of lipoprotein(a) for patients with atherosclerotic cardiovascular disease: A retrospective analysis from the United States.
Fonseca AF; Byrne H; Laguna A; Itani T; Studer R; Heo J; Dillon A; Ferber P; Costa-Scharplatz M
J Manag Care Spec Pharm; 2023 May; 29(5):519-529. PubMed ID: 37121256
[No Abstract] [Full Text] [Related]
9. Association of Prior Atherosclerotic Cardiovascular Disease with Dementia After Stroke: A Retrospective Cohort Study.
Yang Z; Edwards D; Burgess S; Brayne C; Mant J
J Alzheimers Dis; 2020; 77(3):1157-1167. PubMed ID: 32925051
[TBL] [Abstract][Full Text] [Related]
10. High-Risk Atherosclerotic Cardiovascular Disease in a Real-World Employed Japanese Population: Prevalence, Cardiovascular Event Rates, and Costs.
Davis KL; Meyers J; Zhao Z; McCollam PL; Murakami M
J Atheroscler Thromb; 2015; 22(12):1287-304. PubMed ID: 26289083
[TBL] [Abstract][Full Text] [Related]
11. Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease.
Ajufo E; Ayers CR; Vigen R; Joshi PH; Rohatgi A; de Lemos JA; Khera A
JAMA Cardiol; 2021 Feb; 6(2):179-187. PubMed ID: 33112372
[TBL] [Abstract][Full Text] [Related]
12. Association between diseases of despair and atherosclerotic cardiovascular disease among insured adults in the USA: a retrospective cohort study from 2017 to 2021.
Nudy M; Galper K; George DR; Williams BA; Kraschnewski JL; Sinoway L; Brignone E
BMJ Open; 2023 Sep; 13(9):e074102. PubMed ID: 37673458
[TBL] [Abstract][Full Text] [Related]
13. Excess Risk for Atherosclerotic Cardiovascular Outcomes Among US Adults With HIV in the Current Era.
Rosenson RS; Hubbard D; Monda KL; Reading SR; Chen L; Dluzniewski PJ; Burkholder GA; Muntner P; Colantonio LD
J Am Heart Assoc; 2020 Jan; 9(1):e013744. PubMed ID: 31880980
[TBL] [Abstract][Full Text] [Related]
14. Physical Activity, Parental History of Premature Coronary Heart Disease, and Incident Atherosclerotic Cardiovascular Disease in the Atherosclerosis Risk in Communities (ARIC) Study.
Florido R; Zhao D; Ndumele CE; Lutsey PL; McEvoy JW; Windham BG; Pankow JS; Guallar E; Michos ED
J Am Heart Assoc; 2016 Aug; 5(9):. PubMed ID: 27577582
[TBL] [Abstract][Full Text] [Related]
15. Impact of cardiovascular disease on health care economic burden and resource utilization: a retrospective cohort study in adults in the United States with type 2 diabetes with or without stroke, myocardial infarction, and peripheral arterial disease.
King A; Rajpura J; Liang Y; Paprocki Y; Uzoigwe C
Curr Med Res Opin; 2022 Nov; 38(11):1831-1840. PubMed ID: 36134459
[TBL] [Abstract][Full Text] [Related]
16. Patient characteristics and acute cardiovascular event rates among patients with very high-risk and non-very high-risk atherosclerotic cardiovascular disease.
Fonarow GC; Kosiborod MN; Rane PB; Nunna S; Villa G; Habib M; Arellano J; Mues KE; Sun K; Wade RL
Clin Cardiol; 2021 Oct; 44(10):1457-1466. PubMed ID: 34351003
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Impact of Previous Atherosclerotic Cardiovascular Disease on Short- and Long-Term Outcomes in Acute Myocardial Infarction.
Saito Y; Yaginuma H; Asada K; Goto H; Sato T; Kitahara H; Kobayashi Y
Am J Cardiol; 2024 Apr; 217():18-24. PubMed ID: 38402922
[TBL] [Abstract][Full Text] [Related]
18. Dual elevated remnant cholesterol and C-reactive protein in myocardial infarction, atherosclerotic cardiovascular disease, and mortality.
Doi T; Langsted A; Nordestgaard BG
Atherosclerosis; 2023 Aug; 379():117141. PubMed ID: 37217436
[TBL] [Abstract][Full Text] [Related]
19. Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study.
Wadström BN; Pedersen KM; Wulff AB; Nordestgaard BG
Diabetologia; 2023 Dec; 66(12):2238-2249. PubMed ID: 37776347
[TBL] [Abstract][Full Text] [Related]
20. Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm.
Hageman SHJ; McKay AJ; Ueda P; Gunn LH; Jernberg T; Hagström E; Bhatt DL; Steg PG; Läll K; Mägi R; Gynnild MN; Ellekjær H; Saltvedt I; Tuñón J; Mahíllo I; Aceña Á; Kaminski K; Chlabicz M; Sawicka E; Tillman T; McEvoy JW; Di Angelantonio E; Graham I; De Bacquer D; Ray KK; Dorresteijn JAN; Visseren FLJ
Eur Heart J; 2022 May; 43(18):1715-1727. PubMed ID: 35165703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
